CBD demonstrated antibacterial effects against all tested Enterococcus strains, including drug-resistant hospital pathogens, at very low concentrations.
Microbiologists, infectious disease researchers, antimicrobial resistance specialists
What the researchers found
CBD displayed antibacterial properties against all 20 tested clinical strains of E. faecalis and E. faecium with MIC values at or below 1 μg/mL. Higher CBD concentrations produced stronger antibacterial effects. Pure CBD and CBD crystals showed statistically lower MICs than CBD oils. E. faecium was more susceptible than E. faecalis.
Why it matters
Enterococcus bacteria are increasingly resistant to conventional antibiotics and cause serious hospital infections. Finding that CBD works against these multidrug-resistant strains at low concentrations opens a potential new avenue in the fight against antibiotic resistance.
The numbers in context
MIC ≤ 1 μg/mL for all tested strains. 20 clinical strains tested (E. faecalis and E. faecium). 5 CBD oils and 1 CBD crystal product (99% purity) evaluated. Pure CBD significantly more effective than CBD oils.
How the study worked
Pilot study evaluating antimicrobial effects of five CBD oils and one 99% CBD crystal product against 20 clinical strains of Enterococcus species using the microdilution method in Mueller-Hinton broth to determine Minimal Inhibitory Concentrations.
What this study cannot tell us
In vitro pilot study only — lab conditions don't reflect the complexity of treating infections in living organisms. Small number of strains tested. Mechanism of antibacterial action not elucidated. No toxicity or pharmacokinetic data.
How to read the evidence
Pilot in vitro study demonstrates clear antibacterial activity but is far from clinical application. Mechanism and in vivo efficacy unknown.
When this study was published
Published 2026, addressing the growing multidrug-resistant Enterococcus crisis.
The bigger picture
Antibiotic resistance is one of the greatest threats to global health. CBD's antibacterial properties against hospital superbugs suggest cannabinoids could become part of future antimicrobial arsenals — though significant development work remains.
Questions still open
- What is CBD's mechanism of antibacterial action against Enterococcus? Would CBD work synergistically with existing antibiotics? Could CBD-based topical formulations prevent surgical site infections?
Common questions
Can CBD kill bacteria?
Is CBD oil as effective as pure CBD against bacteria?
Read the original research
Cannabidiol (CBD) and Other Cannabinoids as a Promising Alternative Antibacterial Agent-Pilot Study on Enterococcus faecalis and Enterococcus faecium Clinical Strains.
Molecules (Basel, Switzerland), 31(1)
Citation
Kraszewska, Zuzanna; Grudlewska-Buda, Katarzyna; Wnuk, Kacper; Wałecka-Zacharska, Ewa; Gospodarek-Komkowska, Eugenia; Skowron, Krzysztof. (2026). Cannabidiol (CBD) and Other Cannabinoids as a Promising Alternative Antibacterial Agent-Pilot Study on Enterococcus faecalis and Enterococcus faecium Clinical Strains.. Molecules (Basel, Switzerland), 31(1). https://doi.org/10.3390/molecules31010144
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk
- THC and Antibiotics: Is It Safe to Use Cannabis While on Antibiotics